Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00201_DB00730_nanopub.RAuMeEdFhP347VJIOealAQaH1KKkntRV74K0j1FDGEAD4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00201_DB00730 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00201_DB00730 label "DDI between Caffeine and Thiabendazole - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Caffeine by decreasing Caffeine metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Caffeine if Thiabendazole is initiated, discontinued or dose changed. [drugbank_resource:DB00201_DB00730]" assertion.
- drugbank_resource:DB00201_DB00730 identifier "drugbank_resource:DB00201_DB00730" assertion.
- drugbank_resource:DB00201_DB00730 title "DDI between Caffeine and Thiabendazole - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Caffeine by decreasing Caffeine metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Caffeine if Thiabendazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00201 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00201_DB00730 assertion.
- drugbank:DB00730 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00201_DB00730 assertion.